Bellevue Funds - Bellevue Biotech AA CHF

Bellevue Biotech is focused on achieving long-term capital growth by investing primarily in the biotechnology sector. At least two-thirds of its assets are allocated to both direct and indirect equity investments in biotech companies, while up to one third can be invested in other approved financial instruments. The fund may also use derivatives to help reach its investment goals. This specialized approach is tailored for investors looking to gain significant exposure to the biotechnology industry over a long-term period.